<div id="readability-page-1"><div><p>Over the last 7 days, the United States market has risen 2.8%, and over the past 12 months, it is up 9.3%, with earnings forecasted to grow by 14% annually. In such a climate, identifying stocks with strong financials becomes crucial for those seeking value and growth potential. Penny stocks, though often considered niche due to their smaller size or newer status, can present unique opportunities when they demonstrate robust financial health and long-term promise.</p><h3>Top 10 Penny Stocks In The United States</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Share Price</strong></td><td><strong>Market Cap</strong></td><td><strong>Rewards &amp; Risks</strong></td></tr><tr><td>Safe Bulkers (NYSE:SB)</td><td>$3.45</td><td>$361.71M</td><td>✅ 4 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Tuya (NYSE:TUYA)</td><td>$2.39</td><td>$1.44B</td><td>✅ 3 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Perfect (NYSE:PERF)</td><td>$1.86</td><td>$189.44M</td><td>✅ 3 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Smith Micro Software (NasdaqCM:SMSI)</td><td>$1.05</td><td>$18.66M</td><td>✅ 4 ⚠️ 4 View Analysis &gt;</td></tr><tr><td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td><td>$3.315</td><td>$9.95M</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>Flexible Solutions International (NYSEAM:FSI)</td><td>$3.65</td><td>$46.16M</td><td>✅ 4 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>Imperial Petroleum (NasdaqCM:IMPP)</td><td>$2.56</td><td>$77.65M</td><td>✅ 3 ⚠️ 1 View Analysis &gt;</td></tr><tr><td>BAB (OTCPK:BABB)</td><td>$0.8294</td><td>$6.02M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Lifetime Brands (NasdaqGS:LCUT)</td><td>$3.594</td><td>$80.24M</td><td>✅ 3 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>CBAK Energy Technology (NasdaqCM:CBAT)</td><td>$0.7957</td><td>$71.73M</td><td>✅ 4 ⚠️ 1 View Analysis &gt;</td></tr></tbody></table><p>Click here to see the full list of 748 stocks from our  US Penny Stocks screener.</p><p>We're going to check out a few of the best picks from our screener tool.</p><h2>Blade Air Mobility (NasdaqCM:BLDE)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Blade Air Mobility, Inc. offers air transportation and logistics services for hospitals both in the United States and internationally, with a market cap of $234.27 million.</p><p><strong>Operations:</strong> The company generates revenue from two main segments: Medical services, which contributed $146.82 million, and Passenger services, which brought in $101.88 million.</p><p><strong>Market Cap:</strong> $234.27M</p><p>Blade Air Mobility, Inc. has shown resilience despite being currently unprofitable, with a net loss of US$27.31 million for 2024, an improvement from the previous year's US$56.08 million loss. The company benefits from a robust financial position with no debt and short-term assets of US$160.7 million exceeding liabilities significantly, providing a cash runway for over three years based on free cash flow. Recent initiatives include a pilot program in partnership with Skyports Infrastructure aimed at expanding urban air mobility services in New York City, potentially enhancing future revenue streams and operational efficiencies as they transition to electric vertical aircraft operations.</p><ul><li>Dive into the specifics of Blade Air Mobility here with our thorough balance sheet health report.</li><li>Evaluate Blade Air Mobility's prospects by accessing our earnings growth report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis"/><figcaption>NasdaqCM:BLDE Financial Position Analysis as at May 2025</figcaption></figure><h2>Cardlytics (NasdaqGM:CDLX)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom, with a market cap of approximately $960 million.</p><p><strong>Operations:</strong> The company's revenue is primarily derived from its Cardlytics Platform, generating $255.62 million, and its Bridg Platform, contributing $22.68 million.</p><p><strong>Market Cap:</strong> $96M</p><p>Cardlytics, Inc. faces challenges as it remains unprofitable with a net loss of US$189.3 million for 2024, widening from the prior year's loss. Despite trading at good relative value and having short-term assets of US$178 million covering both short- and long-term liabilities, its high net debt to equity ratio of 211.4% raises concerns about financial leverage. The company recently amended its loan facility extending maturity to 2028 without borrowing additional funds, maintaining US$60 million in available credit. Revenue guidance for Q1 2025 is set between US$57-60 million, indicating continued revenue pressures amidst operational volatility.</p><ul><li>Unlock comprehensive insights into our analysis of Cardlytics stock in this financial health report.</li><li>Understand Cardlytics' earnings outlook by examining our growth report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown"/><figcaption>NasdaqGM:CDLX Revenue &amp; Expenses Breakdown as at May 2025</figcaption></figure><h2>Douglas Elliman (NYSE:DOUG)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Douglas Elliman Inc. operates in the real estate services and property technology investment sectors in the United States, with a market cap of approximately $162.22 million.</p><p><strong>Operations:</strong> The company generates its revenue primarily from real estate services and property technology investments in the United States, amounting to $1.05 billion.</p><p><strong>Market Cap:</strong> $162.22M</p><p>Douglas Elliman Inc. operates with a market cap of US$162.22 million and reported revenues of US$1.05 billion, yet remains unprofitable with a negative return on equity (-25.61%). Despite an increase in revenue to US$253.4 million for Q1 2025 from the previous year, the company recorded a net loss of US$5.99 million, an improvement from prior losses but still concerning for investors focused on profitability. The company's short-term assets exceed its short-term liabilities, providing some financial stability; however, long-term liabilities remain uncovered by these assets, highlighting potential risks amidst its ongoing efforts to stabilize operations through recent shelf registration filings and earnings calls.</p><ul><li>Jump into the full analysis health report here for a deeper understanding of Douglas Elliman.</li><li>Gain insights into Douglas Elliman's past trends and performance with our report on the company's historical track record.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown"/><figcaption>NYSE:DOUG Revenue &amp; Expenses Breakdown as at May 2025</figcaption></figure><h2>Summing It All Up</h2><ul><li>Explore the 748 names from our  US Penny Stocks screener here.</li><li>Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><p>If you're looking to trade Cardlytics, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p><p><span>Sponsored Content</span></p></div></div></div>

DOUG

BLDE

SRTA

<p>The U.S. market has risen 2.8% in the past week and 9.3% over the last year, with earnings expected to grow by 14% annually. Amid this growth, penny stocks with strong financials are highlighted, including Blade Air Mobility, Cardlytics, and Douglas Elliman, each showing unique opportunities despite challenges. Blade Air Mobility has a market cap of $234.27M and no debt, while Cardlytics, with a market cap of $960M, faces profitability issues. Douglas Elliman operates with a market cap of $162.22M and reported revenues of $1.05B but remains unprofitable. Investors are encouraged to explore these stocks for potential value and growth.</p>

3 Promising Penny Stocks With Market Caps Over $90M